Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
13F holders, Q3 2024
Institutional positions in Intercure Ltd. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +2 vs. Q2 2024
- Shares held
- 2.65M
- −480.7K (−15.4%) vs. Q2 2024
- Total value
- $5.22M
- −$773.9K (−12.9%) vs. Q2 2024
- New holders
- 7
- 1 more added
- Sold out
- 5
- 5 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INCR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 16 | $764.1K |
| Q1 2026 | 15 | $617.9K |
| Q4 2025 | 18 | $796.3K |
| Q3 2025 | 22 | $3.44M |
| Q2 2025 | 19 | $3.68M |
| Q1 2025 | 15 | $3.50M |
| Q4 2024 | 17 | $4.00M |
| Q3 2024 | 20 | $5.22M |
| Q2 2024 | 19 | $6.04M |
| Q1 2024 | 17 | $8.92M |
| Q4 2023 | 18 | $4.93M |
| Q3 2023 | 20 | $5.43M |
| Q2 2023 | 19 | $5.30M |
| Q1 2023 | 18 | $8.29M |
| Q4 2022 | 15 | $9.75M |
| Q3 2022 | 21 | $21.9M |
| Q2 2022 | 18 | $38.1M |
| Q1 2022 | 19 | $34.8M |
| Q4 2021 | 23 | $26.9M |
| Q3 2021 | 16 | $16.3M |
| Q2 2021 | 2 | $5.37M |
| Q1 2021 | 1 | $8.38M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Intercure Ltd.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ibex Investors LLC | 1,889,658 | $3.80M | 4.35% | 00.0% | Unchanged |
| Toroso Investments, LLC | 229,500 | $461.3K | 0.01% | −230,272−50.1% | Reduced |
| Healthcare of Ontario Pension Plan Trust Fund | 212,500 | $325.1K | 0.00% | 00.0% | Unchanged |
| AdvisorShares Investments LLC | 107,414 | $215.9K | 0.04% | 00.0% | Unchanged |
| Citadel Advisors LLC | 50,712 | $101.9K | 0.00% | −582−1.1% | Reduced |
| Renaissance Technologies LLC | 48,800 | $98.1K | 0.00% | +3,500+7.7% | Added |
| Jane Street Group, LLC | 25,855 | $48.9K | 0.00% | +25,855 | New |
| BlackRock, Inc. | 24,162 | $48.6K | 0.00% | +24,162 | New |
| Virtu Financial LLC | 21,427 | $43.0K | 0.00% | +21,427 | New |
| Geode Capital Management, LLC | 19,375 | $38.9K | 0.00% | 00.0% | Unchanged |
| Quent Capital, LLC | 10,321 | $20.7K | 0.00% | +10,321 | New |
| Morgan Stanley | 4,000 | $8.04K | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 2,371 | $4.77K | 0.00% | −3,696−60.9% | Reduced |
| Financial Network Wealth Advisors LLC | 1,000 | $2.01K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 508 | $1.02K | 0.00% | +508 | New |
| Citigroup Inc | 521 | $987 | 0.00% | +521 | New |
| Advisor Group Holdings, Inc. | 400 | $804 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 44 | $88 | 0.00% | +44 | New |
| Royal Bank of Canada | 196 | $0 | 0.00% | −14−6.7% | Reduced |
| Simplex Trading, LLC | 33 | $0 | 0.00% | −147−81.7% | Reduced |
| Moore Capital Management, LP | 0 | $0 | 0.00% | −97,273−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −87,870−100.0% | Sold out |
| Cambria Investment Management, L.P. | 0 | $0 | 0.00% | −48,930−100.0% | Sold out |
| Toronto Dominion Bank | 0 | $0 | 0.00% | −78−100.0% | Sold out |
| Mirae Asset Global ETFs Holdings Ltd. | 0 | $0 | 0.00% | −98,190−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |